Elevated red blood cell distribution width as a simple prognostic factor in patients with symptomatic multiple myeloma

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Lee, Hyewon ^a   Kong, Sun Young ^b   Sohn, Ji Yeon ^b   Shim, Hyoeun ^b   Youn, Hye Sun ^a   Lee, Sangeun ^a   Kim, Hyun Ju ^a   Eom, Hyeon Seok ^a  

^a Hematologic Oncology Clinic   (South Korea)

^b Department of Laboratory Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; BORTEZOMIB; DOXORUBICIN; HEMOGLOBIN; LENALIDOMIDE; M PROTEIN; STEROID; THALIDOMIDE; VINCRISTINE; IMMUNOGLOBULIN; M-PROTEINS (MYELOMA);

ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW CELL; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CELLULAR DISTRIBUTION; DRUG MEGADOSE; ERYTHROCYTE DISTRIBUTION WIDTH; ERYTHROCYTE PARAMETERS; FEMALE; FOLLOW UP; HUMAN; INDUCTION CHEMOTHERAPY; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; OVERALL SURVIVAL; PLASMA CELL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SURVIVAL TIME; TREATMENT RESPONSE; BLOOD; CLINICAL TRIAL; DISEASE FREE SURVIVAL; MEAN CORPUSCULAR VOLUME; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL RATE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BETA 2-MICROGLOBULIN; BONE MARROW CELLS; DISEASE-FREE SURVIVAL; ERYTHROCYTE INDICES; FEMALE; HEMOGLOBINS; HUMANS; IMMUNOGLOBULINS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM STAGING; PLASMA CELLS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84902160686     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/145619     Document Type: Article

References (34)

1. Simel D. L., DeLong E. R., Feussner J. R., Weinberg J. B., Crawford J., Erythrocyte anisocytosis. Visual inspection of blood films vs automated analysis of red blood cell distribution width. Archives of Internal Medicine 1988 148 4 822 824 2-s2.0-0023927234
2. van Zeben D., Bieger R., van Wermeskerken R. K. A., Castel A., Hermans J., Evaluation of microcytosis using serum ferritin and red blood cell distribution width. European Journal of Haematology 1990 44 2 106 109 2-s2.0-0025311684 (Pubitemid 20172162)
3. Bhambhani K., Aronow R., Lead poisoning and thalassemia trait or iron deficiency. The value of the red blood cell distribution width. American Journal of Diseases of Children 1990 144 11 1231 1233 2-s2.0-0025089113 (Pubitemid 20360626)
4. Tonelli M., Sacks F., Arnold M., Moye L., Davis B., Pfeffer M., Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 2008 117 2 163 168 2-s2.0-38049148378 10.1161/CIRCULATIONAHA.107.727545
5. Arbel Y., Weitzman D., Raz R., Red blood cell distribution width and the risk of cardiovascular morbidity and all-cause mortality. A population-based study. Thrombosis and Haemostasis 2014 111 300 307 10.1160/TH13-07-0567
6. Oh H. J., Park J. T., Kim J. K., Red blood cell distribution width is an independent predictor of mortality in acute kidney injury patients treated with continuous renal replacement therapy. Nephrology Dialysis Transplantation 2012 27 589 594 10.1093/ndt/gfr307
7. Solak Y., Yilmaz M. I., Saglam M., Red cell distribution width is independently related to endothelial dysfunction in patients with chronic kidney disease. The American Journal of the Medical Sciences 2014 347 118 124 10.1097/MAJ.0b013e3182996a96
8. Balta S., Aydogan M., Demirkol S., Cakar M., Akgul E. O., Sarlak H., Red cell distribution width: a novel and simple predictor of mortality in chronic obstructive pulmonary disease. Journal of Chronic Obstructive Pulmonary Disease 2014 10.3109/15412555.2013.813449
9. Wang F., Pan W., Pan S., Ge J., Wang S., Chen M., Red cell distribution width as a novel predictor of mortality in ICU patients. Annals of Medicine 2011 43 1 40 46 2-s2.0-78651407518 10.3109/07853890.2010.521766
10. Purtle S. W., Moromizato T., McKane C. K., Gibbons F. K., Christopher K. B., The association of red cell distribution width at hospital discharge and out-of-hospital mortality following critical illness Critical Care Medicine 2014 42 918 929 10.1097/CCM.0000000000000118
11. Bazick H. S., Chang D., Mahadevappa K., Gibbons F. K., Christopher K. B., Red cell distribution width and all-cause mortality in critically ill patients. Critical Care Medicine 2011 39 8 1913 1921 2-s2.0-79961030278 10.1097/CCM.0b013e31821b85c6
12. Ku N. S., Kim H. W., Oh H. J., Red blood cell distribution width is an independent predictor of mortality in patients with gram-negative bacteremia. Shock 2012 38 2 123 127 10.1097/SHK.0b013e31825e2a85
13. de Gonzalo-Calvo D., de Luxán-Delgado B., Rodríguez- González S., García-Macia M., Suárez F. M., Solano J. J., Rodríguez-Colunga M. J., Coto-Montes A., Interleukin 6, soluble tumor necrosis factor receptor I and red blood cell distribution width as biological markers of functional dependence in an elderly population: a translational approach. Cytokine 2012 58 2 193 198 2-s2.0-84859217428 10.1016/j.cyto.2012.01. 005
14. Greipp P. R., Miguel J. S., Dune B. G. M., Crowley J. J., Barlogie B., Bladé J., Boccadoro M., Child J. A., Harousseau J.-L., Kyle R. A., Lahuerta J. J., Ludwig H., Morgan G., Powles R., Shimizu K., Shustik C., Sonneveld P., Tosi P., Turesson I., Westin J., International staging system for multiple myeloma. Journal of Clinical Oncology 2005 23 15 3412 3420 2-s2.0-20644460600 10.1200/JCO.2005.04.242
15. Dewald G. W., Therneau T., Larson D., You K. L., Fink S., Smoley S., Paternoster S., Adeyinka A., Ketterling R., van Dyke D. L., Fonseca R., Kyle R., Relationship of patient survival and chromosome anomalies detected in metaphase and/or interphase cells at diagnosis of myeloma. Blood 2005 106 10 3553 3558 2-s2.0-27744568383 10.1182/blood-2005-05-1981 (Pubitemid 41609193)
16. Stewart A. K., Fonseca R., Prognostic and therapeutic significance of myeloma genetics and gene expression profiling. Journal of Clinical Oncology 2005 23 26 6339 6344 2-s2.0-27244439379 10.1200/JCO.2005.05.023 (Pubitemid 46218844)
17. Bataille R., Boccadoro M., Klein B., Durie B., Pileri A., C-reactive protein and β -2 microglobulin produce a simple and powerful myeloma staging system. Blood 1992 80 3 733 737 2-s2.0-0026708195
18. Tienhaara A., Pulkki K., Mattila K., Irjala K., Pelliniemi T.-T., Serum immunoreactive interleukin-6 and C-reactive protein levels in patients with multiple myeloma at diagnosis. British Journal of Haematology 1994 86 2 391 393 2-s2.0-0028307584 (Pubitemid 24199010)
19. Mantovani A., Garlanda C., Inflammation and multiple myeloma: the Toll connection. Leukemia 2006 20 6 937 938 2-s2.0-33744479425 10.1038/sj.leu.2404229 (Pubitemid 43797281)
20. Bataille R., Harousseau J. L., Multiple myeloma. The New England Journal of Medicine 1997 336 1657 1664 10.1056/NEJM199706053362307 (Pubitemid 27231321)
21. Nishimoto N., Interleukin-6 as a therapeutic target in candidate inflammatory diseases. Clinical Pharmacology and Therapeutics 2010 87 4 483 487 2-s2.0-77949875590 10.1038/clpt.2009.313
22. Mahindra A., Laubach J., Raje N., Munshi N., Richardson P. G., Anderson K., Latest advances and current challenges in the treatment of multiple myeloma. Nature Reviews Clinical Oncology 2012 9 3 135 143 2-s2.0-84857913363 10.1038/nrclinonc.2012.15
23. Hutchison C. A., Batuman V., Behrens J., Bridoux F., Sirac C., Dispenzieri A., Herrera G. A., Lachmann H., Sanders P. W., The pathogenesis and diagnosis of acute kidney injury in multiple myeloma. Nature Reviews Nephrology 2012 8 1 43 51 2-s2.0-84455205655 10.1038/nrneph.2011.168
24. Kyle R. A., Rajkumar S. V., Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia 2009 23 1 3 9 2-s2.0-58249097191 10.1038/leu.2008.291
25. Sharma S., Nemeth E., Chen Y.-H., Goodnough J., Huston A., Roodman G. D., Ganz T., Lichtenstein A., Involvement of hepcidin in the anemia of multiple myeloma. Clinical Cancer Research 2008 14 11 3262 3267 2-s2.0-50349085287 10.1158/1078-0432.CCR-07-4153
26. Baicus C., Caraiola S., Rimbas M., Patrascu R., Baicus A., Utility of routine hematological and inflammation parameters for the diagnosis of cancer in involuntary weight loss. Journal of Investigative Medicine 2011 59 6 951 955 2-s2.0-84856455671 10.231/JIM.0b013e31822467a3
27. Nunez J., Nunez E., Rizopoulos D., Red blood cell distribution width is longitudinally associated with mortality and anemia in heart failure patients. Circulation Journal 2014 78 2 410 418 10.1253/circj.CJ-13-0630
28. Cauthen C. A., Tong W., Jain A., Tang W. H. W., Progressive rise in red cell distribution width is associated with disease progression in ambulatory patients with chronic heart failure. Journal of Cardiac Failure 2012 18 2 146 152 2-s2.0-84856481839 10.1016/j.cardfail.2011.10.013
29. Rezende S. M., Lijfering W. M., Rosendaal F. R., Cannegieter S. C., Hematologic variables and venous thrombosis: red cell distribution width and blood monocyte count are associated with an increased risk. Haematologica 2014 99 194 200 10.3324/haematol.2013.083840
30. Zoller B., Melander O., Svensson P., Engstrom G., Red cell distribution width and risk for venous thromboembolism: a population-based cohort study. Thrombosis Research 2014 133 3 334 339 10.1016/j.thromres.2013.12.013
31. Seretis C., Seretis F., Lagoudianakis E., Gemenetzis G., Salemis N. S., Is red cell distribution width a novel biomarker of breast cancer activity? Data from a pilot study. Journal of Clinical Medicine Research 2013 5 2 121 126
32. Warwick R., Mediratta N., Shackcloth M., Shaw M., McShane J., Poullis M., Preoperative red cell distribution width in patients undergoing pulmonary resections for non-small-cell lung cancer. European Journal Cardio-Thoracic Surgery 2014 45 1 108 113 10.1093/ejcts/ezt275
33. Koma Y., Onishi A., Matsuoka H., Increased red blood cell distribution width associates with cancer stage and prognosis in patients with lung cancer. PLoS ONE 2013 8 11 e80240 10.1371/journal.pone.0080240
34. Brightwell R. F., Crawford G. P. M., Cale J. B., Pedler P. J., Bittles A. H., Ageing and the haematological profiles of an Australian community. Annals of Human Biology 1998 25 1 1 10 2-s2.0-0031605244 (Pubitemid 128469145)